Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV antigen-specific DC/DC-T adoptive immunotherapy with or without entecavir in HBeAg-positive chronic hepatitis B
ChiCTR-ONRC-14004393Phase 4Recruiting
- Sponsor
- 180th Hospital of the People's Liberation Army
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir in Chronic Hepatitis B (CHB) (5 arms), sponsored by 180th Hospital of the People's Liberation Army. Primary endpoints: Serum HBV DNA level, Serum HBsAg level and 2 more. Started Apr 2014; status: recruiting.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-ONRC-14004393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14004393.